Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin

Journal of Clinical Oncology

Volumn 17, Issue 7, 1999, Pages 2237-2243

  Herman, Eugene H ^a   Zhang, Jun ^a   Lipshultz, Steven E ^a   Rifai, Nader ^a   Chadwick, Douglas ^a   Takeda, Kazuyo ^a   Yu, Zu Xi ^a   Ferrans, Victor J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; TROPONIN T;

ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CARDIOMYOPATHY; CARDIOTOXICITY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; DOSE RESPONSE; HEART MUSCLE BIOPSY; HEART MUSCLE INJURY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOISOTOPE VENTRICULOGRAPHY; RAT;

EID: 0032983504     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.7.2237     Document Type: Article

References (33)

1. Ganz WI, Sridhar KS, Ganz SS, et al: Review of tests for monitoring doxorubicin-induced cardiomyopathy. Oncology 53:461-470, 1996
2. Mair J: Progress in myocardial damage detection: New biochemical markers for clinicians. Crit Rev Clin Lab Sci 34:1-66, 1997
3. Katus HA, Remppis A, Scheffold T, et al: Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol 67:1360-1367, 1991
4. Katus HA, Remppis A, Neumann FJ, et al: Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 83:902-912, 1991
5. Mair J, Artner-Dworzak E, Lechleitner P, et al: Cardiac troponin T in diagnosis of acute myocardial infarction. Clin Chem 37:845-852, 1991
6. Bleuel H, Deschl U, Bertsch T, et al: Diagnostic efficiency of troponin T measurements in rats with experimental myocardial cell damage. Exp Toxicol Pathol 47:121-127, 1995
7. Katus HA, Remppis A, Looser S, et al: Enzyme linked immuno assay of cardiac troponin T for the detection of acute myocardial infarction in patients. J Mol Cell Cardiol 21:1349-1353, 1989
8. Katus HA, Looser S, Hallermayer K, et al: Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clin Chem 38:386-393, 1992
9. Raggi A, Grand RJ, Moir AJ, et al: Structure-function relationships in cardiac troponin T. Biochim Biophys Acta 997:135-143, 1989
10. Pearlstone JR, Carpenter MR, Smillie LB: Amino acid sequence of rabbit cardiac troponin T. J Biol Chem 261:16795-16810, 1986
11. Wilkinson JM, Grand RJ: Comparison of amino acid sequence of troponin I from different striated muscles. Nature 271:31-35, 1978
12. Muller-Bardorff M, Hallermayer K, Schroder A, et al: Improved troponin T ELISA specific for cardiac troponin T isoform: Assay development and analytical and clinical validation. Clin Chem 43:458-466, 1997
13. Ricchiuti V, Voss EM, Ney A, et al: Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim. Clin Chem 44:1919-1924, 1998
14. Wu AH, Feng YJ, Moore R, et al: Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I: American Association for Clinical Chemistry Subcommittee on cTnI Standardization. Clin Chem 44:1198-1208, 1998
15. Fink FM, Genser N, Fink C, et al: Cardiac troponin T and creatine kinase MB mass concentrations in children receiving anthracycline chemotherapy. Med Pediatr Oncol 25:185-189, 1995
16. Ottlinger ME, Sallan S, Rifai N, et al: Myocardial damage in doxorubicin-treated children: A study of serum cardiac troponin T. Proc Am Soc Clin Oncol 14:345, 1995 (abstr)
17. Lipshultz SE, Rifai N, Sallan SE, et al: Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury. Circulation 96:2641-2648, 1997
18. Seino Y, Tomita Y, Nagai Y, et al: Cardioprotective effects of ACE-inhibitor (Cilazapril) on adriamycin cardiotoxicity in spontaneously hypertensive rats. Circulation 88:1-633, 1993 (abstr)
19. Herman EH, Lipshultz SE, Rifai N, et al: Use of cardiac troponin T levels as an indicator of doxorubicin-induced cardiotoxicity. Cancer Res 58:195-197, 1998
20. Herman EH, Ferrans VJ, Ardalan B, et al: Comparison of the severity of the chronic cardiotoxicity produced by doxorubicin in normotensive and hypertensive rats. Toxicol Appl Pharmacol 78:202-214, 1985
21. Herman EH, El-Hage A, Ferrans VJ: Protective effect of ICRF-187 on doxorubicin-induced cardiac and renal toxicity in spontaneously hypertensive (SHR) and normotensive (WKY) rats. Toxicol Appl Pharmacol 92:42-53, 1988
22. Ferrans VJ, Sanchez JA, Herman EH: Pathologic anatomy of animal models of anthracycline-induced cardiotoxicity, in Muggia F, Speyer J (eds): Cancer and the Heart. Baltimore, MD, Johns Hopkins University, 1992, pp 89-113
23. Ferrans VJ, Sanchez JA, Herman EH: Role of myocardial biopsy in the diagnosis of anthracycline toxicity, in Muggia FM, Green MD, Speyer JL (eds): Cancer Treatment and the Heart. Baltimore, MD, Johns Hopkins University, 1992, pp 198-216
24. Billingham ME: Role of endomyocardial biopsy in diagnosis and treatment of heart disease, in Silver MD (ed): Cardiovascular Pathology. New York, NY, Churchill Livingstone, 1991, pp 1465-1486
25. Lefrak EA, Pitha J, Rosenheim S, et al: A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 32:302-314, 1973
26. Hamm CW, Ravkilde J, Gerhardt W, et al: The prognostic value of serum troponin T in unstable angina. N Engl J Med 327:146-150, 1992
27. Katus HA, Haller C, Muller-Bardorff M, et al: Cardiac troponin T in end-stage renal disease patients undergoing chronic maintenance hemodialysis. Clin Chem 41:1201-1203, 1995 (letter)
28. Franz WM, Remppis A, Kandolf R, et al: Serum troponin T: Diagnostic marker for acute myocarditis. Clin Chem 42:340-341, 1996 (letter)
29. Myers CE, Gianni L, Simone CB, et al: Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin-iron complex. Biochemistry 21:1707-1712, 1982
30. DeAtley SM, Aksenov MY, Aksenova MV, et al: Adriamycin induces protein oxidation in erythrocyte membranes. Pharmacol Toxicol 83:62-68, 1998
31. Kragten JA, Hermens WT, van Dieijen-Visser MP: Cardiac troponin T release into plasma after acute myocardial infarction: Only fractional recovery compared with enzymes. Ann Clin Biochem 33:314-323, 1996
32. Ottlinger ME, Pearsall L, Rifai N, et al: New developments in the biochemical assessment of myocardial injury in children: Troponins T and I as highly sensitive and specific markers of myocardial injury. Pediatr Cardiol 8:71-81, 1998
33. O'Brien PJ, Dameron GW, Beck ML, et al: Cardiac troponin T is a sensitive, specific biomarker of cardiac injury in laboratory animals. Lab Anim Sci 47:486-495, 1997